Ebu Bekir Sıddık Yılmaz

Dr. Ebu Bekir Sıddık Yılmaz

Perinatology, Ankara City Hospital, Ankara, Turkey (Türkiye)
orcid
Zeynep Yalçınkaya

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Serenat Eris YalcinSerenat Eris Yalcin
Serenat Eris Yalcin
MOMustafa Rasit OZLER
Mustafa Rasit OZLER
YYYakup Yalcin
Yakup Yalcin
ESERKAN SAĞLAM
ERKAN SAĞLAM
Ebu Bekir Sıddık YılmazEbu Bekir Sıddık Yılmaz
Ebu Bekir Sıddık Yılmaz
NNNuray Nerez
Nuray Nerez
Background/Objectives: We aimed to investigate the relationship between early pregnancy inflammatory indices and adverse perinatal outcomes in pregnancies complicated by pregestational diabetes mellitus (PREGDM) and to evaluate their predictive value, particularly for preterm birth and composite adverse perinatal outcome (CAPO). Methods: This retrospective study included 140 women with PREGDM and 140 age-matched controls. Early pregnancy (8–14 weeks) inflammatory indices [the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune–inflammation index (SII), systemic inflammation response index (SIRI)], and C-reactive protein (CRP) were calculated from complete blood counts. Associations with preterm birth and CAPO were analyzed using correlation, ROC analysis, and multivariate logistic regression adjusted for maternal age, BMI, HbA1c, and parity. Results: All inflammatory indices were significantly higher in the PREGDM group compared to controls (p < 0.05). Preterm birth, macrosomia, cesarean delivery, NICU admission, and CAPO were more frequent in PREGDM pregnancies (all p < 0.001). On univariate analysis, NLR, PLR, MLR, SII, and SIRI were significantly higher in women with preterm birth (p < 0.05), but not in those with CAPO. ROC curves showed modest discriminative ability of NLR, PLR, and SII for preterm birth (AUC 0.64–0.66), while AUCs for CAPO prediction were close to 0.5. In multivariate analysis, inflammatory indices were not independent predictors of either outcome. Only HbA1c (OR: 1.71, 95% CI 1.20–2.43, p = 0.003) and parity (OR: 1.62, 95% CI 1.08–2.45, p = 0.021) independently predicted preterm birth, and similarly HbA1c (OR: 1.68, 95% CI 1.14–2.46, p = 0.008) and parity (OR: 1.49, 95% CI 1.02–2.15, p = 0.037) predicted CAPO. Conclusions: Early pregnancy inflammatory indices were associated with preterm birth in univariate analyses but lost significance after adjustment for maternal and metabolic risk factors. HbA1c and parity remained the only independent predictors of adverse outcomes in PREGDM pregnancies. Inflammatory indices may provide supplementary information but should not be used as stand-alone predictors; they may instead be incorporated into multiparametric models with established clinical and metabolic markers to improve risk stratification.

28 August 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
Ebu Bekir Sıddık YılmazEbu Bekir Sıddık Yılmaz
Ebu Bekir Sıddık Yılmaz
ESErkan Sağlam
Erkan Sağlam
SYSerenat Yalcin
Serenat Yalcin
MÖMustafa Raşit Özler
Mustafa Raşit Özler
Objective: Intrahepatic cholestasis of pregnancy (ICP) is associated with adverse perinatal outcomes. Accurate and timely diagnosis is essential to minimize maternal and fetal risks. The standard diagnostic method—measurement of fasting serum bile acids (BA)—poses challenges due to limited availability, high cost, and delayed results. This study aimed to evaluate the diagnostic and prognostic utility of the aspartate aminotransferase to platelet ratio index (APRI) and the De Ritis ratio in ICP. Methods: This retrospective case-control study included 238 pregnant women, categorized into three groups: mild ICP (n = 62), severe ICP (n = 57), and healthy controls (n = 119). Demographic, biochemical, and perinatal outcomes were compared among the groups. APRI and De Ritis ratios were calculated and analyzed using receiver operating characteristic (ROC) curves and correlation analyses. Results: APRI levels were significantly elevated in ICP patients and demonstrated strong diagnostic performance for identifying ICP (cut-off: 0.295; AUC = 0.842). The De Ritis ratio was significantly lower in both ICP groups compared with controls (cut-off: 1.097; AUC = 0.770). APRI also correlated with disease severity (cut-off: 0.615 for severe ICP; AUC = 0.868). Higher APRI values were associated with increased neonatal intensive care unit (NICU) admissions and lower gestational age and birth weight. Conclusions: APRI and De Ritis ratios are simple, inexpensive, and non-invasive markers that may aid in the diagnosis and severity assessment of ICP. They could serve as useful alternatives in clinical settings where BA testing is limited or unavailable.

10 July 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
ESERKAN SAĞLAM
ERKAN SAĞLAM
MOMustafa Rasit OZLER
Mustafa Rasit OZLER
Ebu Bekir Sıddık YılmazEbu Bekir Sıddık Yılmaz
Ebu Bekir Sıddık Yılmaz
Cervical cerclage is a surgical procedure aimed at providing mechanical support to the cervix in patients with cervical insufficiency. This study aimed to investigate the relationship between preoperatively evaluated systemic inflammatory markers — the Systemic Immune-Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Neutrophil-to-Monocyte Ratio (NMR) — and perinatal outcomes in pregnant women undergoing cervical cerclage, as well as to compare the distribution of these markers across different cerclage indication groups (history, physical examination, ultrasound). This retrospective study included 116 singleton pregnancies who underwent cervical cerclage at Bursa City Hospital between January 1, 2021, and December 30, 2024. Systemic inflammatory markers were assessed using hemogram values obtained within 24 h before the surgical procedure. Demographic data, hematologic parameters, and perinatal outcomes of all patients were recorded. Inflammatory indices (SII, SIRI, PLR, etc.) were calculated. Correlation analyses were conducted to evaluate the relationship between inflammatory markers and perinatal outcomes. Inflammatory markers with significant correlations were further assessed via Receiver Operating Characteristic (ROC) analysis for their predictive performance. Comparisons between groups were also performed. Patients were divided into three groups based on the indication for cerclage: history-based, physical examination (PE) findings, and ultrasound (USG) findings. Among all patients who underwent cervical cerclage, significant negative correlations were observed between SII, PLR, and SIRI values and both gestational age and Apgar scores. For predicting preterm birth before 37 weeks, SII had an AUC of 0.654; for SIRI, the AUC was 0.622. In the subgroup analysis for delivery before 34 weeks, predictive performance improved: SII (AUC: 0.673), PLR (AUC: 0.647), and SIRI (AUC: 0.634). For low 1st minute Apgar scores, SII (AUC: 0.636) and PLR (AUC: 0.626) showed predictive utility, while for 5th minute Apgar < 7, SII maintained the highest predictive value (AUC: 0.631).In the comparison across cerclage indication groups, SII and PLR values were also found to be significantly higher in the PE and USG groups compared to the history group (p < 0.05). Additionally, gestational age at delivery, birth weight, and Apgar scores were significantly lower in the PE group. The negative correlations observed between SII, PLR, SIRI values and gestational age and Apgar scores support the potential role of these markers as predictive biomarkers for preterm birth and adverse neonatal outcomes. Simple and cost-effective hematologic parameters may serve as valuable tools in the management of pregnant women undergoing cervical cerclage.

22 July 2025 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Open access
ESERKAN SAĞLAM
ERKAN SAĞLAM
SYSerenat Eris Yalçın
Serenat Eris Yalçın
MOMustafa Rasit OZLER
Mustafa Rasit OZLER
Ebu Bekir Sıddık YılmazEbu Bekir Sıddık Yılmaz
Ebu Bekir Sıddık Yılmaz
NNNuray Nerez
Nuray Nerez
This study aimed to investigate whether thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), and the fT3/fT4 ratio-measured during the first and second trimesters-are associated with the development of gestational diabetes mellitus (GDM) in euthyroid pregnant women. Their predictive value was evaluated using tertile-based logistic regression. In this retrospective cohort study, 200 euthyroid pregnant women without thyroid disease or treatment history were included. GDM was diagnosed according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. Thyroid parameters were measured in the first (9-14 weeks) and second (22-28 weeks) trimesters. Tertile-based univariate and multivariate logistic regression analyses were conducted, adjusting for maternal age, BMI, smoking, and family history of diabetes. Women in the highest tertile (tertile 3) of first-trimester fT3 (>3.61 pg/mL) and fT3/fT4 ratio (>0.27) had a significantly increased risk of GDM (adjusted OR = 9.72 and 4.05, respectively; p < 0.001). Conversely, being in the highest tertile of TSH (tertile 3 > 2.34 µIU/mL) during both trimesters was associated with a significantly lower risk of GDM (OR = 0.32-0.04; p < 0.001). TSH levels increased, while fT3 and fT4 levels decreased significantly across trimesters (p < 0.001). GDM was associated with lower gestational age at delivery (p < 0.001), increased NICU admission (p = 0.041), and a modest positive correlation between first-trimester fT3/fT4 ratio and birth weight (r = 0.15; p = 0.034). Being in the highest tertiles of fT3 and fT3/fT4 ratio during the first trimester-despite remaining within the euthyroid range-was linked to elevated GDM risk. In contrast, the highest TSH tertiles in both trimesters were associated with a decreased risk. These findings suggest that even subtle thyroid hormone variations within normal limits may influence glucose metabolism and support the utility of early thyroid function evaluation for predicting gestational metabolic risk.

2 July 2025 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
ESERKAN SAĞLAM
ERKAN SAĞLAM
MOMustafa Rasit OZLER
Mustafa Rasit OZLER
Ebu Bekir Sıddık YılmazEbu Bekir Sıddık Yılmaz
Ebu Bekir Sıddık Yılmaz
SYSıddık Yılmaz
Sıddık Yılmaz
MBMevlut Bucak
Mevlut Bucak
The etiology of intrahepatic cholestasis of pregnancy (ICP) is not fully understood; however, genetic, hormonal, environmental factors, and inflammation are believed to contribute to its development. This study aimed to investigate the relationship between systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), and neutrophil-to-monocyte ratio (NMR) levels with disease severity in ICP and to evaluate their potential in predicting adverse perinatal outcomes. A total of 240 pregnant women who delivered at Bursa City Hospital between 2019 and 2024 were retrospectively analyzed. Based on fasting serum bile acid (SBA) levels, patients were divided into three groups: control (SBA < 10 µmol/L), mild (SBA 10–40 µmol/L), and severe (SBA ≥ 40 µmol/L) cholestasis. Inflammatory indices were calculated using complete blood count. Blood samples had been collected at the time of diagnosis, between 28 and 36 weeks of gestation during the third trimester, and prior to the initiation of any treatment. Intergroup comparisons and correlation analyses were conducted. The predictive value of these indices was assessed using receiver operating characteristic (ROC) analysis. No significant differences were found between groups in WBC and other complete blood count parameters. Only NMR was significantly higher in the severe cholestasis group compared to the control group (p = 0.0057). SII and SIRI levels did not differ significantly among the groups. Gestational age at delivery, birth weight, Apgar scores, and neonatal intensive care unit (NICU) admission rates were significantly worse in the cholestasis groups than in controls (p < 0.001). SII showed a negative correlation with gestational age and 5th-minute Apgar score. In ROC analysis, SII predicted preterm birth with an AUC of 0.600 (cut-off: 897.35; sensitivity: 57%; specificity: 67%) and predicted low 5th-minute Apgar scores with an AUC of 0.669 (cut-off: 1248.38; sensitivity: 75%; specificity: 83%). The SII and the SIRI may not be reliable markers for the diagnosis or severity assessment of ICP. However, the SII may serve as a potential predictor for preterm birth and low Apgar scores. NMR was significantly elevated in severe ICP patients, suggesting its potential diagnostic value, which should be supported by further studies.

1 December 2025 in International Journal of Women's Health
Verified
Journal Article
Open access
Ebu Bekir Sıddık YılmazEbu Bekir Sıddık Yılmaz
Ebu Bekir Sıddık Yılmaz
Serenat Eris YalcinSerenat Eris Yalcin
Serenat Eris Yalcin
Second-trimester glycated hemoglobin (HbA1c) has been proposed as a marker of adverse pregnancy outcomes, yet its predictive value across gestational diabetes mellitus (GDM), pregestational diabetes mellitus (PGDM), and non-diabetic pregnancies remains unclear. This study assessed whether mid-pregnancy HbA1c predicts adverse perinatal outcomes and identified a clinically meaningful threshold. This retrospective cohort included 460 singleton pregnancies delivered between January 2021 and January 2025 at Bursa City Hospital. Participants were categorized as GDM (n = 203), PGDM (n = 58), or healthy controls (n = 199). HbA1c was measured at 24–28 gestational weeks. An ROC-derived cut-off of 5.3% for predicting macrosomia (>4000 g) was used for subgroup analyses. Perinatal outcomes included gestational age at delivery, delivery mode, birth weight, Apgar scores, and neonatal intensive care unit (NICU) admission. Correlation, ROC, and multivariate logistic regression analyses were performed. Median HbA1c levels were highest in the PGDM group (6.50%), followed by GDM (5.36%) and controls (4.93%) (p = 0.038). Women with HbA1c >5.3% had higher rates of preterm birth (p = 0.005), cesarean delivery (p = 0.012), and macrosomia (p = 0.004). ROC analysis showed moderate predictive ability for macrosomia (AUC = 0.642), preterm birth (AUC = 0.602), and cesarean delivery (AUC = 0.562). In multivariate analysis, maternal BMI independently predicted macrosomia (OR = 1.07; 95% CI: 1.01–1.14; p = 0.02), whereas HbA1c showed a positive but nonsignificant association (OR = 1.35; p = 0.13). Second-trimester HbA1c values above 5.3% were associated with increased risks of preterm birth, cesarean delivery, and macrosomia. Although HbA1c did not independently predict adverse outcomes after adjustment, it may serve as a useful adjunct biomarker for perinatal risk stratification and could contribute to multivariable prediction models.